The DOI matches its Crossref record; 303 of the 303 references it cites were found in a registry or an index.
Fluoxetine versus other types of pharmacotherapy for depression
Open accessAbstract
BACKGROUND: Depression is common in primary care and is associated with marked personal, social and economic morbidity, thus creating significant demands on service providers. The antidepressant fluoxetine has been studied in many randomised controlled trials (RCTs) in comparison with other conventional and unconventional antidepressants. However, these studies have produced conflicting findings.Other systematic reviews have considered selective serotonin reuptake inhibitor (SSRIs) as a group which limits the applicability of the indings for fluoxetine alone. Therefore, this review intends to provide specific and clinically useful information regarding the effects of fluoxetine for depression compared with tricyclics (TCAs), SSRIs, serotonin-noradrenaline reuptake inhibitors (SNRIs), monoamineoxidase inhibitors (MAOIs) and newer agents, and other conventional and unconventional agents. OBJECTIVES: To assess the effects of fluoxetine in comparison with all other antidepressive agents for depression in adult individuals with unipolar major depressive disorder. SEARCH METHODS: We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Review Group Controlled Trials Register (CCDANCTR)to 11May 2012. This register includes relevant RCTs from the Cochrane Central Register of Controlled Trials (CENTRAL) (all years),MEDLINE (1950 to date), EMBASE (1974 to date) and PsycINFO (1967 to date). No language restriction was applied. Reference lists of relevant papers and previous systematic reviews were handsearched. The pharmaceutical company marketing fluoxetine and experts in this field were contacted for supplemental data. SELECTION CRITERIA: All RCTs comparing fluoxetine with any other AD (including non-conventional agents such as hypericum) for patients with unipolar major depressive disorder (regardless of the diagnostic criteria used) were included. For trials that had a cross-over design only results from the first randomisation period were considered. DATA COLLECTION AND ANALYSIS: Data were independently extracted by two review authors using a standard form. Responders to treatment were calculated on an intention-to-treat basis: dropouts were always included in this analysis. When data on dropouts were carried forward and included in the efficacy evaluation, they were analysed according to the primary studies; when dropouts were excluded from any assessment in the primary studies, they were considered as treatment failures. Scores from continuous outcomes were analysed by including patients with a final assessment or with the last observation carried forward. Tolerability data were analysed by calculating the proportion of patients who failed to complete the study due to any causes and due to side effects or inefficacy. For dichotomous data, odds ratios (ORs) were calculated with 95% confidence intervals (CI) using the random-effects model. Continuous data were analysed using standardised mean differences (SMD) with 95% CI. MAIN RESULTS: A total of 171 studies were included in the analysis (24,868 participants). The included studies were undertaken between 1984 and 2012. Studies had homogenous characteristics in terms of design, intervention and outcome measures. The assessment of quality with the risk of bias tool revealed that the great majority of them failed to report methodological details, like the method of random sequence generation, the allocation concealment and blinding. Moreover, most of the included studies were sponsored by drug companies, so the potential for overestimation of treatment effect due to sponsorship bias should be considered in interpreting the results. Fluoxetine was as effective as the TCAs when considered as a group both on a dichotomous outcome (reduction of at least 50% on the Hamilton Depression Scale) (OR 0.97, 95% CI 0.77 to 1.22, 24 RCTs, 2124 participants) and a continuous outcome (mean scores at the end of the trial or change score on depression measures) (SMD 0.03, 95% CI -0.07 to 0.14, 50 RCTs, 3393 participants). On a dichotomousoutcome, fluoxetine was less effective than dothiepin or dosulepin (OR 2.13, 95% CI 1.08 to 4.20; number needed to treat (NNT) =6, 95% CI 3 to 50, 2 RCTs, 144 participants), sertraline (OR 1.37, 95% CI 1.08 to 1.74; NNT = 13, 95% CI 7 to 58, 6 RCTs, 1188 participants), mirtazapine (OR 1.46, 95% CI 1.04 to 2.04; NNT = 12, 95% CI 6 to 134, 4 RCTs, 600 participants) and venlafaxine(OR 1.29, 95% CI 1.10 to 1.51; NNT = 11, 95% CI 8 to 16, 12 RCTs, 3387 participants). On a continuous outcome, fluoxetine was more effective than ABT-200 (SMD -1.85, 95% CI -2.25 to -1.45, 1 RCT, 141 participants) and milnacipran (SMD -0.36, 95% CI-0.63 to -0.08, 2 RCTs, 213 participants); conversely, it was less effective than venlafaxine (SMD 0.10, 95% CI 0 to 0.19, 13 RCTs,3097 participants). Fluoxetine was better tolerated than TCAs considered as a group (total dropout OR 0.79, 95% CI 0.65 to 0.96;NNT = 20, 95% CI 13 to 48, 49 RCTs, 4194 participants) and
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression
Geddes, J. R., Freemantle, N., Mason, J. M., Eccles, M., & Boynton, J. R. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001851 · Cited by 112
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
Diagnostic Criteria for Use in Psychiatric Research
Feighner, J. P. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,715
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Imputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568
Self-citationStatistics Notes: Detecting skewness from summary information: Table 1
Altman, D. G., & Bland, J. M. (1996) · BMJ · doi:10.1136/bmj.313.7066.1200 · Cited by 1,278
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
Cha, M., Eastwaad, S., Hartan, R., Maher, D., Olkin, I., Pitkin, R., Rennie, D., Schulz, K. F., Simel, D. L., & Straup, D. F. (1996) · Cited by 737
Wong, D. T., Bymaster, F. P., & Engleman, E. A. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00209-o · Cited by 647
Cipriani, A., Barbui, C., Salanti, G., Rendell, J., Brown, R., Stockton, S., Purgato, M., Spineli, L. M., Goodwin, G. M., & Geddes, J. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60873-8 · Cited by 631
Self-citationSystematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
Edwards, J. G., & Anderson, I. (1999) · Drugs · doi:10.2165/00003495-199957040-00005 · Cited by 458
Randomisation to protect against selection bias in healthcare trials
Odgaard-Jensen, J., Vist, G. E., Timmer, A., Kunz, R., Akl, E. A., Schünemann, H., Briel, M., Nordmann, A. J., Pregno, S., & Oxman, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000012.pub3 · Cited by 439
The Discovery of Fluoxetine Hydrochloride (Prozac)
Wong, D. T., Perry, K. W., & Bymaster, F. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1821 · Cited by 418
Zimmerman, M., Mattia, J. I., & Posternak, M. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.469 · Cited by 382
Bosc, M., Dubini, A., & Polin, V. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00420-3 · Cited by 373
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K., Lux, L., Van Noord, M., Mager, U., Thieda, P., Gaynes, B. N., Wilkins, T., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00009 · Cited by 355
Meta-analytical studies on new antidepressants
Anderson, I. M. (2001) · British Medical Bulletin · doi:10.1093/bmb/57.1.161 · Cited by 351
Duloxetine in the Treatment of Major Depressive Disorder: A Double-Blind Clinical Trial
Goldstein, D. J., Mallinckrodt, C., Lu, Y., & Demitrack, M. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0309 · Cited by 334
Novel melatonin-based therapies: potential advances in the treatment of major depression
Hickie, I. B., & Rogers, N. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60095-0 · Cited by 334
Furukawa, T. A., Guyatt, G. H., & Griffith, L. E. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.72 · Cited by 318
Self-citationSimilar Effectiveness of Paroxetine, Fluoxetine, and Sertraline in Primary Care: A Randomized Trial
Kroenke, K., West, S. L., Swindle, R., Gilsenan, A., Eckert, G. J., Dolor, R., Stang, P., Zhou, X.-H., Hays, R., & Weinberger, M. (2001) · JAMA · doi:10.1001/jama.286.23.2947 · Cited by 312
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311
Self-citationNoorbala, A. A., Akhondzadeh, S., Tahmacebi-Pour, N., & Jamshidi, A. H. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.11.004 · Cited by 311
Sertraline versus other antidepressive agents for depression
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub2 · Cited by 305
Self-citationSertraline versus other antidepressive agents for depression
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub4 · Cited by 299
Self-citationClerc, G. E., Ruimy, P., & Verdeau-Paillès, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00001 · Cited by 298
Simon, G. E. (1996) · JAMA · doi:10.1001/jama.275.24.1897 · Cited by 294
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1735 · Cited by 285
Fava, M., Judge, R., Hoog, S. L., Nilsson, M. E., & Koke, S. C. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1109 · Cited by 263
148th Annual Meeting of the American Psychiatric Association
(1996) · European Addiction Research · doi:10.1159/000319611 · Cited by 259
A Comparison of Fluoxetine Imipramine and Placebo in Patients with Bipolar Depressive Disorder
COHN, J. B., COLLINS, G., ASHBROOK, E., & WERNICKE, J. F. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198910000-00006 · Cited by 257
Akhondzadeh Basti, A., Moshiri, E., Noorbala, A.-A., Jamshidi, A.-H., Abbasi, S. H., & Akhondzadeh, S. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.010 · Cited by 247
Silverstone, P. H., Ravindran, A., & the Venlafaxine XR 360 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0105 · Cited by 246
Stark, P., & Hardison, C. D. (1985) · PubMed · Cited by 239
Schrader, E. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015020-00001 · Cited by 225
Rush, A. J., Armitage, R., Gillin, J. C., Yonkers, K. A., Winokur, A., Moldofsky, H., Vogel, G. W., Kaplita, S. B., Fleming, J. B., Montplaisir, J., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00092-4 · Cited by 215
Fluvoxamine versus other anti-depressive agents for depression
Omori, I. M., Watanabe, N., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R., & Furukawa, T. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006114.pub2 · Cited by 209
Self-citationPredictors of an acute antidepressant response to fluoxetine and sertraline
Flament, M. F., Lane, R. M., Zhu, R., & Ying, Z. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199909000-00001 · Cited by 209
Escitalopram versus other antidepressive agents for depression
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532.pub2 · Cited by 190
Self-citationNelson, J. C., Mazure, C. M., Jatlow, P. I., Bowers, M. B., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.007 · Cited by 189
Development of a quality assessment instrument for trials of treatments for depression and neurosis
Moncrieff, J., Churchill, R., Drummond, D. C., & McGuire, H. (2001) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.108 · Cited by 185
Brambilla, P., Cipriani, A., Hotopf, M., & Barbui, C. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-837806 · Cited by 181
Self-citationFeighner, J. P., & Cohn, J. B. (1985) · PubMed · Cited by 171
Licinio, J., O'Kirwan, F., Irizarry, K., Merriman, B., Thakur, S., Jepson, R., Lake, S., Tantisira, K. G., Weiss, S. T., & Wong, M.-L. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 168
Winokur, A., DeMartinis, N. A., McNally, D. P., Gary, E. M., Cormier, J. L., & Gary, K. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1013 · Cited by 165
Duloxetine versus other anti-depressive agents for depression
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533.pub2 · Cited by 165
Self-citationA Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients
Newhouse, P. A., Krishnan, K. R. R., Doraiswamy, P. M., Richter, E. M., Batzar, E. D., & Clary, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0804 · Cited by 163
Rudolph, R. L., & Feiger, A. D. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00067-1 · Cited by 158
Mirtazapine versus other antidepressive agents for depression
Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., Churchill, R., & Furukawa, T. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006528.pub2 · Cited by 158
Self-citationWheatley, D. P., Moffaert, M. V., Timmerman, L., & Kremer, C. M. E. (1998) · PubMed · Cited by 157
Bech, P., Cialdella, P., Haugh, M., Birkett, M. A., Hours, A. T., Boissel, J., & Tollefson, G. D. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.176.5.421 · Cited by 157
Chouinard, G. (1985) · PubMed · Cited by 157
Fluoxetine versus other types of pharmacotherapy for depression
Cipriani, A., Brambilla, P., Furukawa, T. A., Geddes, J. R., Gregis, M., Hotopf, M. H., Malvini, L., & Barbui, C. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub2 · Cited by 156
Self-citationMartényi, F., Dossenbach, M. R. K., Mraz, K., & Metcalfe, S. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00089-x · Cited by 154
Dieric, M., Ravizza, U., Realini, R., & Martin, A. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00292-8 · Cited by 152
Fluoxetine versus phenelzine in atypical depression
Pande, A. C., Birkett, M. A., Fechner-Bates, S., Haskett, R. F., & Greden, J. F. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00628-1 · Cited by 150
Schatzberg, A. F., & Roose, S. P. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000194645.70869.3b · Cited by 145
Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?
Doraiswamy, P. M., Krishnan, K., Oxman, T. E., Jenkyn, L. R., Coffey, D., Burt, T., & Clary, C. M. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.12.m1137 · Cited by 145
Wheatley, D. P., van Moffaert, M., Timmerman, L., Kremer, C. M. E., & The Mirtazapine-Fluoxetine Study Group (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0606 · Cited by 145
D, M. F. M., Alpert, J. E., Nierenberg, A. A., Mischoulon, D., Otto, M. W., Zajecka, J., Murck, H., & Rosenbaum, J. F. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000178416.60426.29 · Cited by 142
Kwon, J. S., Youn, T., & Jung, H. Y. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00057-2 · Cited by 140
D, M. F. M., Rosenbaum, J. F., HOOG, S. L., Tepner, R. G., Kopp, J. B., & Nilsson, M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00131-7 · Cited by 140
Hale, A. S., Corral, R. M., Mencacci, C., Ruiz, J. S., Severo, C. A., & Gentil, V. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833a86aa · Cited by 137
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Jb, C., & Wilcox, C. M. (1985) · PubMed · Cited by 133
Joyce, P. R., Mulder, R., Luty, S. E., Sullivan, P., McKenzie, J. M., Abbott, R. M., & Stevens, I. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.01026.x · Cited by 129
Six Months of Treatment for Depression: Outcome and Predictors of the Course of Illness
Mulder, R. T., Joyce, P. R., Frampton, C. M. A., Luty, S. E., & Sullivan, P. F. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.95 · Cited by 127
Escitalopram in the Treatment of Depressed Elderly Patients
Kasper, S. F., de Swart, H., & Andersen, H. F. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.10.884 · Cited by 126
Cassano, G. B., Puca, F., Scapicchio, P. L., Trabucchi, M., & Italian Study Group on Depression in Elderly Patients (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0504 · Cited by 121
Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder
Massana, J., llerb, H.-J. M., Burrows, G. D., & Montenegro, R. M. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199903000-00003 · Cited by 117
McGrath, P. J., Stewart, J. W., Janal, M. N., Petkova, E., Quitkin, F. M., & Klein, D. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.344 · Cited by 117
Keller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dunner, D. L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0812 · Cited by 116
Silverstone, P. H., & Salinas, E. O. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n07a04 · Cited by 116
Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression
Aguglia, E., Casacchia, M., Cassano, G. B., Faravelli, C., Ferrari, G., Giordano, P., Pancheri, P., Ravizza, L., Trabucchi, M., Bolino, F., et al. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00010 · Cited by 115
Levkovitz, Y., Caftori, R., Avital, A., & Richter-Levin, G. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00780-8 · Cited by 112
Wilde, J. D., Spiers, R., Mertens, C., Bartholomé, F., Schotte, G., & Leyman, S. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03345.x · Cited by 111
A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients
Muijen, M., Roy, D. H., Silverstone, T., Mehmet, A., & Christie, M. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06353.x · Cited by 110
Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression
Behnke, K., Jensen, G. S., Graubaum, H., & Gruenwald, J. (2002) · Advances in Therapy · doi:10.1007/bf02850017 · Cited by 110
Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner, J. P., Gardner, E. A., Johnston, J. A., Batey, S. R., Khayrallah, M. A., Ascher, J. A., & Lineberry, C. G. (1991) · PubMed · Cited by 107
(1995) · PubMed · Cited by 105
Gillin, J. C., Rapaport, M., Erman, M. K., Winokur, A., & Albala, B. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0502 · Cited by 104
Smeraldi, E. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00139-0 · Cited by 104
Thompson, C. M., Peveler, R., Stephenson, D., & McKendrick, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.338 · Cited by 103
Suicide, depression, and antidepressants
Cipriani, A., Barbui, C., & Geddes, J. R. (2005) · BMJ · doi:10.1136/bmj.330.7488.373 · Cited by 102
Self-citationLight, S. N., Heller, A. S., Johnstone, T., Kolden, G. G., Peterson, M. J., Kalin, N. H., & Davidson, R. J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.031 · Cited by 102
Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse
Iovieno, N., van Nieuwenhuizen, A., Clain, A., Baer, L., & Nierenberg, A. A. (2011) · Depression and Anxiety · doi:10.1002/da.20768 · Cited by 98
Armitage, R., Yonkers, K., Cole, D., & Rush, A. J. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00004 · Cited by 97
Berk, M. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.t01-3-01063.x-i1 · Cited by 97
Başterzi, A. D., Yazıcı, K. U., Aslan, E., Delıalıoğlu, N., Taşdelen, B., Acar, Ş. T., & Yazıcı, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.016 · Cited by 96
Bakish, D., Cavazzoni, P. A., Chudzik, J., Ravindran, A., & Hrdina, P. D. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00040-6 · Cited by 96
Silva, J. C. E. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0703 · Cited by 95
NE, W. S., & LUDWIG, M. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312002-00006 · Cited by 93
D, M. F. M., HOOG, S. L., Judge, R., Kopp, J. B., Nilsson, M., & Gonzales, J. S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00006 · Cited by 91
Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death.
K., J. (1950) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2980804 · Cited by 91
(1991) · PubMed · Cited by 89
Clayton, A. H., Zajecka, J., Ferguson, J. M., Filipiak‐Reisner, J. K., Brown, M. T., & Schwartz, G. E. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000066456.73432.09 · Cited by 89
Dubini, A., Bosc, M., & Polin, V. (1997) · PubMed · Cited by 88
Are we going to increase the use of antidepressants up to that of benzodiazepines?
Ciuna, A., Andretta, M., Corbari, L., Levi, D., Mirandola, M., Sorio, A., & Barbui, C. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0810-8 · Cited by 87
Self-citationPatris, M., Bouchard, J. M., Bougerol, T., Jf, C., Chevalier, J.-F., Clerc, G., Cyran, C., Amerongen, P. V., Lemming, O. M., & Petersen, H. E. H. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606000-00007 · Cited by 85
Do noradrenaline and serotonin differentially affect social motivation and behaviour?
Dubini, A., Bosc, M., & Polin, V. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00419-7 · Cited by 85
Peveler, R. C., Kendrick, T., Buxton, M., Longworth, L., Baldwin, D. S., Moore, M. V., Chatwin, J., Goddard, J. R., Thornett, A. M., Smith, H. E., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9160 · Cited by 83
A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression
D, M. F. M., Amsterdam, J. D., Deltito, J. A., Salzman, C., Schwaller, M., & Dünner, D. L. (1998) · Annals of Clinical Psychiatry · doi:10.1023/a:1022337927842 · Cited by 82
Comparison of Equivalence between the St. John’s Wort Extract LoHyp-57 and Fluoxetine
Harrer, G., Schmidt, U., Kuhn, U., & Biller, A. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300417 · Cited by 82
Moclobemide and fluoxetine in atypical depression: a double-blind trial
Lönnqvist, J. K., Sihvo, S., Syvälahti, E. K. G., & Kiviruusu, O. H. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90015-9 · Cited by 82
Hunter, A. M., Leuchter, A. F., Morgan, M. L., & Cook, I. A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1426 · Cited by 81
BYERLEY, W. F., REIMHERR, F. W., WOOD, D. R., & GROSSER, B. I. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198804000-00005 · Cited by 80
Tzanakaki, M., Guazzelli, M., Nimatoudis, I., & Zissis, N. P. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015010-00004 · Cited by 80
Chronobiology and Psychiatric Disorders
Halaris, A. E. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198901000-00014 · Cited by 80
Lönnqvist, J. K., Sintonen, H., Syvälahti, E. K. G., Appelberg, B., Koskinen, T., Männikkö, T., Mehtonen, O. ‐., Naarala, M., Sihvo, S., AUVINEN, J. P., et al. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01530.x · Cited by 80
Comparative Efficacy of Sertraline vs. Fluoxetine in Patients Age 70 or Over With Major Depression
Finkel, S. I., Richter, E. M., Clary, C. M., & Batzar, E. D. (1999) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199908000-00006 · Cited by 76
Comparison of the Effects of Mirtazapine and Fluoxetine in Severely Depressed Patients
Versiani, M., Moreno, R. A., van Moorsel, C. J. A., Schutte, A. J., & Study, C. E. O. A. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00004 · Cited by 76
Nemeroff, C. B., & Thase, M. E. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.009 · Cited by 76
Baldomero, E. B., Ubago, J. G., Cercós, C. L., Ruiloba, J. V., Calvo, C. G., Lopez, R., & for the ARGOS Study Group (2005) · Depression and Anxiety · doi:10.1002/da.20080 · Cited by 75
Ghaeli, P., Shahsavand, E., Mesbahi, M., Kamkar, M.-Z., Sadeghi, M., & Dashti‐Khavidaki, S. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000132441.27854.0d · Cited by 74
Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety
Nayer, A. D., Geerts, S., Ruelens, L., Schittecatte, M., Bleeker, E. D., Eeckhoutte, I. V., Evrard, J.-L., Linkowski, P., Fossion, P., Leyman, S., et al. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002857 · Cited by 73
Paroxetine in the elderly depressed patient
Geretsegger, C., Böhmer, F., & Ludwig, M. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400910-00004 · Cited by 73
Fluoxetine Versus Trazodone in Depressed Geriatric Patients
Falk, W. E., Rosenbaum, J. F., Otto, M. W., Zusky, P. M., Weilburg, J. B., & Nixon, R. A. (1989) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198878900200407 · Cited by 73
Bjerkenstedt, L., Edman, G., Alken, R. G., & Mannel, M. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0532-z · Cited by 72
Compliance in depressed patients treated with fluoxetine or amitriptyline
Demyttenaere, K., Ganse, E. H. V., Grégoire, J. C., Gaens, E., & Mesters, P. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199801000-00002 · Cited by 71
Personality and Clinical Predictors of Recurrence of Depression
Berlanga, C., Heinze, G., Torres, M., Apiquián, R., & Caballero, A. (1999) · Psychiatric Services · doi:10.1176/ps.50.3.376 · Cited by 70
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Feighner, J. P. (1985) · PubMed · Cited by 70
Tignol, J. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312002-00003 · Cited by 70
Long-term Outcomes of Initial Antidepressant Drug Choice in a "Real World" Randomized Trial
Simon, G. E., Heiligenstein, J., Revicki, D. A., VonKorff, M., Katon, W. J., Ludman, E., Grothaus, L., & Wagner, E. (1999) · Archives of Family Medicine · doi:10.1001/archfami.8.4.319 · Cited by 69
Fluoxetine in depressed patients: a comparison with imipramine.
Bremner, J. D. (1984) · PubMed · Cited by 69
Are All Antidepressants Really the Same? The Case of Fluoxetine: A Systematic Review
Cipriani, A., Barbui, C., Brambilla, P., Furukawa, T. A., Hotopf, M. H., & Geddes, J. R. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0601 · Cited by 68
Self-citationKocsis, J. H., Thase, M. E., Trivedi, M. H., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Dunner, D. L., Hirschfeld, R. M. A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0706 · Cited by 67
Reboxetine versus fluoxetine: an overview of efficacy and tolerability.
Massana, J. (1998) · PubMed · Cited by 66
Fluoxetine and Desipramine in Major Depressive Disorder
Bowden, C. L., Schatzberg, A. F., ROSENBAUM, A., Contreras, S. A., SAMSON, J. A., Dessain, E. C., & Sayler, M. E. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00002 · Cited by 64
"Wish Bias" in Antidepressant Drug Trials?
Barbui, C., Cipriani, A., Brambilla, P., & Hotopf, M. H. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000115665.45074.0d · Cited by 63
Self-citationFairweather, D. B., Kerr, J., Harrison, D. A., Moon, C. A. L., & Hindmarch, I. (1993) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470080108 · Cited by 63
Moreno, R. A., Teng, C. T., de Almeida, K. M., & Tavares, H. (2006) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462006000100007 · Cited by 62
Barbui, C., & Cipriani, A. (2011) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796011000515 · Cited by 61
Self-citationComparative effects of fluoxetine and amitriptyline on cardiac function.
Upward, J., Edwards, J. G., Goldie, A., & Waller, D. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03397.x · Cited by 61
Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine
Demyttenaere, K., Mesters, P., Boulanger, B., Dewé, W., Delsemme, M.-H., Grégoire, J. C., & Ganse, E. H. V. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00225-1 · Cited by 61
Fluoxetine in Major Depression: Efficacy, Safety and Effects on Sleep Polygraphic Variables
KERKHOFS, M., RIELAERT, C., MAERTELAER, V. D., LINKOWSKI, P., CZARKA, M., & MENDLEWICZ, J. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199010000-00002 · Cited by 61
Entsuah, R., Shaffer, M., & Zhang, J. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00024-9 · Cited by 60
Fluoxetine Compared with Imipramine in the Treatment of Inpatient Depression A Multicenter Trial
Beasley, C. M., Holman, S., & Potvin, J. H. (1993) · Annals of Clinical Psychiatry · doi:10.3109/10401239309148983 · Cited by 60
Sechter, D., Troy, S., Paternetti, S., & Boyer, P. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)80714-7 · Cited by 59
Placebo, Prozac and PLoS: significant lessons for psychopharmacology
Horder, J., Matthews, P., & WALDMANN, R. J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110372544 · Cited by 59
Controlled comparison of milnacipran and fluoxetine in major depression
Ansseau, M., Papart, P., Troisfontaines, B., Bartholomé, F., Bataille, M., Charles, G. A., Schittecatte, M., Darimont, P., Devoitille, J.-M., Wilde, J. D., et al. (1994) · Psychopharmacology · doi:10.1007/bf02245454 · Cited by 58
A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression
Feighner, J. P., Boyer, W. F., Merideth, C., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198904000-00004 · Cited by 58
Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression
Geddes, J. R., Freemantle, N., Mason, J. M., Eccles, M., & Boynton, J. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001851.pub2 · Cited by 58
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
Chouinard, G., Saxena, B., Bélanger, M.-C., Ravindran, A., Bakish, D., Beauclair, L., Morris, P., Vasavan Nair, N. P., Manchanda, R., Reesal, R., et al. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00188-8 · Cited by 57
How well do antidepressants work in older people? A systematic review of Number Needed to Treat
Katona, C., & Livingston, G. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00332-3 · Cited by 57
Andreoli, V. M., Caillard, V., Deo, R., RYBAKOWSKI, J. K., & Versiani, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00010 · Cited by 56
Dunlop, B. W., Li, T., Kornstein, S. G., Friedman, E. S., Rothschild, A. J., Pedersen, R., Ninan, P. T., Keller, M. B., & Trivedi, M. H. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.032 · Cited by 56
Guelfi, J., Ansseau, M., Corruble, E., Samuelian, J., Tonelli, I., Tournoux, A., & Plétan, Y. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199805000-00005 · Cited by 56
Milnacipran versus other antidepressive agents for depression
Nakagawa, A., Watanabe, N., Omori, I. M., Barbui, C., Cipriani, A., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006529.pub2 · Cited by 55
Self-citationAgosti, V., & McGrath, P. J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00393-7 · Cited by 55
D-fenfluramine-induced prolactin and cortisol release in major depression: Response to treatment
O’Keane, V., McLoughlin, D. M., & Dinan, T. G. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90009-u · Cited by 54
Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.
Altamura, A. C., Novellis, F. D., Guercetti, G., INVERNIZZI, G., Percudani, M., & Montgomery, S. (1989) · PubMed · Cited by 52
Development of an antidepressant compliance questionnaire
Demyttenaere, K., Bruffaerts, R., Albert, A., Mesters, P., Dewé, W., Debruyckere, K., & Sangeleer, M. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00350.x · Cited by 52
A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders
Williams, R. B., Edwards, R. A., Newburn, G., Mullen, R., Menkes, D. B., & Segkar, C. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300730-00006 · Cited by 52
Correlation between patient and clinician assessments of depression severity in the PREVENT study
Dunlop, B. W., Li, T., Kornstein, S. G., Friedman, E. S., Rothschild, A. J., Pedersen, R., Ninan, P. T., & Keller, M. B. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.02.008 · Cited by 52
Should Anxiety and Insomnia Influence Antidepressant Selection
Simon, G. E., Heiligenstein, J. H., Grothaus, L. C., Katon, W. J., & Revicki, D. A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0202 · Cited by 52
Moffaert, M. V., Bartholomé, F., Cosyns, P. R., Nayer, A. R. D., & Mertens, C. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100505 · Cited by 51
Krishnan, K. R. R., Doraiswamy, P. M., & Clary, C. M. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00168-8 · Cited by 51
Hong, C., Hu, W.-H., Chen, C.-C., Hsiao, C., Tsai, S., & Ruwe, F. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0810 · Cited by 50
A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients
Díaz-Martínez, A., Benassini, O., Ontiveros, A., Gonzalez, S., Salín, R. J., Basquedano, G., & Martínez, R. A. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80056-8 · Cited by 50
Clinical and Economic Comparison of Sertraline and Fluoxetine in the Treatment of Depression
Boyer, P., Danion, J., Bisserbe, J. C., Hotton, J., & Troy, S. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813010-00015 · Cited by 49
Fudge, J. L., Perry, P. J., Garvey, M. J., & Kelly, M. W. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90079-n · Cited by 49
A Comparison of Fluvoxamine and Fluoxetine in the Treatment of Major Depression
Rapaport, M. H., Coccaro, E. F., Sheline, Y. I., Perse, T., Holland, P. J., Fabre, L. F., & Bradford, D. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00005 · Cited by 49
Clinical trials of antidepressant medications are producing meaningless results
Parker, G. B., Anderson, I. M., & Haddad, P. M. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.2.102 · Cited by 49
Hunter, A. M., Leuchter, A. F., Cook, I. A., & Abrams, M. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01560.x · Cited by 48
TOLLEFSON, G. D., GREIST, J. H., JEFFERSON, J. W., HEILIGENSTEIN, J. H., SAYLER, M. E., TOLLEFSON, S. L., & KOBACK, K. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00003 · Cited by 47
Keller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dünner, D. L., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.040 · Cited by 46
Beasley, C. M., Sayler, M. E., Bosomworth, J. C., & Wernicke, J. F. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199106000-00004 · Cited by 46
Stratta, P., Bolino, F., Cupillari, M., & CASACCHIA, M. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100630-00007 · Cited by 46
A Comparison of Fluoxetine and Amitriptyline in the Treatment of Major Depression
Keegan, D. A., Bowen, R., Blackshaw, S. L., SALEH, S., Dayal, N., REMILLARD, F., Shrikhande, S., PEREZ, S. C., Boulton, A. L., RICHARDSON, S., et al. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00007 · Cited by 46
The introductory placebo washout: A retrospective evaluation
Reimherr, F. W., Ward, M. F., & Byerley, W. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90160-1 · Cited by 45
Fluoxetine Versus Moclobemide: Cross-Comparison Between the Time Courses of Improvement
Stassen, H. H., Angst, J., & Delini‐Stula, A. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979192 · Cited by 45
Norman, T. R., Gupta, R. K., Burrows, G. D., Parker, G. B., & Judd, F. K. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300810-00004 · Cited by 44
A Controlled Comparison of Fluoxetine and Amitriptyline in Depressed Out-patients
Young, J. P. R., Coleman, A., & LADER, M. H. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.3.337 · Cited by 44
Lôo, H., Sáiz, P. A., Silva, J. A. C. E., Ansseau, M., Herrington, R. N., Vaz‐Serra, A., Dilling, H., & Risio, S. D. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00009-9 · Cited by 44
Fluoxetine vs Amitriptyline in the Treatment of Depressed Out-patients
Laakmann, G., Blaschke, D., Engel, R. R., & Schwarz, A. (1988) · The British Journal of Psychiatry · doi:10.1192/s0007125000297316 · Cited by 44
Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
Schatzberg, A. F. (1998) · PubMed · Cited by 43
Moosa, M. Y. H., Panz, V. R., Jeenah, F. Y., et al. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095341.32154.8f · Cited by 42
Fluoxetine versus trazodone in the treatment of outpatients with major depression.
Debus, J. R., Rush, A. J., Himmel, C., Tyler, D., Polatin, P. B., & Weissenburger, J. E. (1988) · PubMed · Cited by 41
A Comparative Trial of a New Antidepressant, Fluoxetine
Levine, S., Deo, R., & Mahadevan, K. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.150.5.653 · Cited by 41
A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
Perry, P. J., Garvey, M. J., Kelly, M. W., Cook, B. L., Dunner, F. J., & Winokur, G. (1989) · PubMed · Cited by 40
Fluvoxamine versus fluoxetine in major depressive episode: a double‐blind randomised comparison
Jean Dalery, A., & Honig, A. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.490 · Cited by 40
CORNE, S. J., & HALL, J. R. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00007 · Cited by 39
Narayan, M., Cellar, J. S., Mallison, R. T., Price, L. H., & Nelson, J. C. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00011 · Cited by 38
Versiani, M., Ontiveros, A., Mazzotti, G., Ospina, J., D??vila, J., Mata, S., Pacheco, A., Plewes, J., Tamura, R., & Palacios, M. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199911000-00001 · Cited by 38
Lf, F., Mb, S., & Tm, I. (1991) · PubMed · Cited by 38
A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression
de Jonghe, F. E. R. E. R., Ravelli, D. P., & Tuynman-Qua, H. G. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014440 · Cited by 37
Cited by
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Imputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568
Self-citationCross-trial prediction of treatment outcome in depression: a machine learning approach
Chekroud, A. M., Zotti, R. J., Shehzad, Z., Gueorguieva, R., Johnson, M. K., Trivedi, M. H., Cannon, T. D., Krystal, J. H., & Corlett, P. R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00471-x · Cited by 676
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Bauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477
Metadata
- Authors
- Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-07-17
- Volume
- 2013
- Issue
- 7
- Pages
- CD004185-CD004185
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1868235462
- Cited by
- 252
- References
- 303
- FWCI
- 13.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.